These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24863510)

  • 1. Fluency in Parkinson's disease: disease duration, cognitive status and age.
    Brabo NC; Minett TS; Ortiz KZ
    Arq Neuropsiquiatr; 2014 May; 72(5):349-55. PubMed ID: 24863510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action verbal fluency in Parkinson's patients.
    Rodrigues IT; Ferreira JJ; Coelho M; Rosa MM; Castro-Caldas A
    Arq Neuropsiquiatr; 2015 Jun; 73(6):520-5. PubMed ID: 26083889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Speech fluency profile on different tasks for individuals with Parkinson's disease.
    Juste FS; Andrade CRF
    Codas; 2017 Jul; 29(4):e20160130. PubMed ID: 28746463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Speech fluency profile in cluttering individuals.
    Oliveira CM; Bernardes AP; Broglio GA; Capellini SA
    Pro Fono; 2010; 22(4):445-50. PubMed ID: 21271097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical correlates of repetitive speech disorders in Parkinson's disease.
    Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Sato M; Hattori M; Kawabata K; Hara K; Nakatsubo D; Maesawa S; Kajita Y; Katsuno M; Sobue G
    J Neurol Sci; 2019 Jun; 401():67-71. PubMed ID: 31029883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairments of speech fluency in Lewy body spectrum disorder.
    Ash S; McMillan C; Gross RG; Cook P; Gunawardena D; Morgan B; Boller A; Siderowf A; Grossman M
    Brain Lang; 2012 Mar; 120(3):290-302. PubMed ID: 22099969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive or Cognitive-Motor Executive Function Tasks? Evaluating Verbal Fluency Measures in People with Parkinson's Disease.
    Barbosa AF; Voos MC; Chen J; Francato DCV; Souza CO; Barbosa ER; Chien HF; Mansur LL
    Biomed Res Int; 2017; 2017():7893975. PubMed ID: 28904971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of parkinsonian syndromes according to differences in executive functions.
    Lange KW; Tucha O; Alders GL; Preier M; Csoti I; Merz B; Mark G; Herting B; Fornadi F; Reichmann H; Vieregge P; Reiners K; Becker G; Naumann M
    J Neural Transm (Vienna); 2003 Sep; 110(9):983-95. PubMed ID: 12938023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dopaminergic medication on speech dysfluency in Parkinson's disease: a longitudinal study.
    Tykalová T; Rusz J; Čmejla R; Klempíř J; Růžičková H; Roth J; Růžička E
    J Neural Transm (Vienna); 2015 Aug; 122(8):1135-42. PubMed ID: 25583417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of developmental speech dysfluencies in individuals with Parkinson's disease.
    Hartelius L
    Folia Phoniatr Logop; 2014; 66(3):132-7. PubMed ID: 25413693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive function assessment in idiopathic Parkinson's disease.
    Piovezan MR; Teive HA; Piovesan EJ; Mader MJ; Werneck LC
    Arq Neuropsiquiatr; 2007 Dec; 65(4A):942-6. PubMed ID: 18094850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verbal fluency deficits in Parkinson's disease: a meta-analysis.
    Henry JD; Crawford JR
    J Int Neuropsychol Soc; 2004 Jul; 10(4):608-22. PubMed ID: 15327739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apathy and Reduced Speed of Processing Underlie Decline in Verbal Fluency following DBS.
    Foley JA; Foltynie T; Zrinzo L; Hyam JA; Limousin P; Cipolotti L
    Behav Neurol; 2017; 2017():7348101. PubMed ID: 28408788
    [No Abstract]   [Full Text] [Related]  

  • 14. Acoustic investigation of stress patterns in Parkinson's disease.
    Tykalova T; Rusz J; Cmejla R; Ruzickova H; Ruzicka E
    J Voice; 2014 Jan; 28(1):129.e1-129.e8. PubMed ID: 24094802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interlocking finger test in patients with Parkinson's disease and healthy subjects.
    Souza CP; Oliveira GN; Foss MP; Tumas V
    J Clin Neurosci; 2016 Jul; 29():145-8. PubMed ID: 26960261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Parkinson's Disease-Cognitive Rating Scale (PD-CRS): normative values from 268 healthy Italian individuals.
    Santangelo G; Lagravinese G; Battini V; Chiorri C; Siciliano M; Abbruzzese G; Vitale C; Barone P
    Neurol Sci; 2017 May; 38(5):845-853. PubMed ID: 28224328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual signal auto-correlation to evaluate speech in Parkinson's disease patients.
    Pereira JC; Schelp AO; Montagnoli AN; Gatto AR; Spadotto AA; de Carvalho LR
    Arq Neuropsiquiatr; 2006 Dec; 64(4):912-5. PubMed ID: 17220994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speech prosody impairment predicts cognitive decline in Parkinson's disease.
    Rektorova I; Mekyska J; Janousova E; Kostalova M; Eliasova I; Mrackova M; Berankova D; Necasova T; Smekal Z; Marecek R
    Parkinsonism Relat Disord; 2016 Aug; 29():90-5. PubMed ID: 27237105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relations between Sensorimotor Integration and Speech Disorders in Parkinson's Disease.
    Millian-Morell L; Lopez-Alburquerque T; Rodriguez-Rodriguez A; Gomez-Nieto R; Carro J; Meilan JJG; Martinez-Sanchez F; Sancho C; Lopez DE
    Curr Alzheimer Res; 2018; 15(2):149-156. PubMed ID: 28847285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression impairs executive functioning in Parkinson disease patients with low educational level.
    Kummer A; Harsányi E; Dias FM; Cardoso F; Caramelli P; Teixeira AL
    Cogn Behav Neurol; 2009 Sep; 22(3):167-72. PubMed ID: 19741326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.